Supplements have Entered the Mainstream, and Why Credibility Matters More Than Ever

In Italy, supplements are no longer a niche. They are a mass-market reality, and a clear signal for the future of consumer health.

In Italy, food supplements are no longer a niche category. They have become a mass-market reality, a retail force, and increasingly, a strategic signal for companies operating across food, pharma, and health-related consumer sectors.

According to the research echoed across major media coverage, the sector is now worth more than €5 billion, with more than 35 million Italians reporting supplement use over the past 12 months and 318 million packs sold annually. More importantly, 85% of respondents reported using supplements in the past year.

That matters for a simple reason: when a category reaches this level of penetration, it is no longer just a product story. It becomes a market story.

And market stories matter because they reveal deeper shifts in consumer behaviour, trust, channel dynamics, and the way people increasingly manage everyday wellbeing.

One of the clearest signals is frequency of use. One in three Italians reportedly consumes supplements every month, suggesting that supplementation is becoming part of recurring habits rather than an occasional demand. This is what makes the category strategically relevant for companies looking at long-term positioning rather than short-term sales alone.

The purchase journey tells an equally important story. Pharmacy remains the leading channel, accounting for 61% of purchases. This is not just a channel shift. It is the sign of a category becoming more hybrid, more competitive, and more dependent on trust-led omnichannel execution.

Demand patterns also show that the market is broadening. Immune support and physical energy remain among the most visible drivers. Still, the category now spans a wider range of wellbeing needs, from sleep and mood to gynecology, beauty, weight management and cardio-metabolic. That creates room for sharper segmentation, better portfolio architecture, and more targeted value propositions.

For managers across food, pharma, and wellness, the strategic implication is clear: the next phase of growth will not be driven solely by visibility. It will be shaped by the ability to combine three assets at once:

portfolio relevance –  scientific credibility –  channel execution

That is exactly where companies can begin to differentiate.

Where Cor.Con. International fits in

In this context, Cor.Con. International can be read as part of a market evolution in which the breadth of offering is no longer enough on its own. As the supplements category becomes more mainstream, companies are increasingly expected to demonstrate not only a relevant product portfolio but also a credible scientific foundation for how that portfolio is built, communicated, and brought to market.

For Cor.Con., this creates a strategic opportunity.

A well-structured portfolio allows a company to respond to increasingly diversified consumer needs across everyday wellbeing. But in a market where trust remains central, portfolio strength becomes more valuable when it is paired with scientific seriousness: formulation rationale, evidence-based positioning, clarity of communication, and the ability to speak credibly to both commercial partners and health-facing stakeholders.

In other words, the competitive advantage is no longer just having products in the right categories. It is about supporting those categories with a level of scientific credibility that strengthens brand trust and makes the portfolio more sustainable over time.

This is particularly relevant in a market where pharmacy remains the leading channel and where consumers still rely heavily on doctors and pharmacists for guidance, even as digital purchasing continues to grow. In that environment, scientific credibility is not simply a regulatory or technical asset. It is a business asset.

For Cor.Con., that means the conversation is potentially bigger than product availability alone. It is about how portfolio strategy and scientific credibility can work together to reinforce positioning, enhance partner engagement, and build long-term relevance in a category that is growing larger and more demanding.

Why this matters now

Another signal should not be overlooked: this story did not remain confined to specialist publications. According to Integratori & Salute’s communication, the survey launch generated 197 media placements, with further amplification through video distribution and broad republication across national and local outlets. Coverage also reached major business media, including Il Sole 24 Ore.

That breadth of attention matters because it suggests the category is no longer being observed only as a specialist niche. It is increasingly part of the wider business conversation. This is an inference based on the scope of the media coverage, not a direct statement from any one source.

So, the real question is no longer whether supplements matter in Italy.

They do.

The more strategic question is which companies are best positioned to create value in a market where trust, evidence, and portfolio relevance increasingly determine who earns credibility and who remains interchangeable.

In mature health-related categories, growth is rarely just about selling more. It is about becoming more trusted, more relevant, and easier to choose.

What do you think will be the real differentiator in the next phase of the supplements market: science, portfolio quality, channel execution, or education?